West Virginia Sits on $34M Medical Cannabis Revenue With No Spending Plan

The state has collected substantial medical cannabis program fees but allocated zero dollars, reflecting ongoing legislative gridlock over fund deployment.

FILE — harvest · My 420 Tours / CC BY-SA 4.0

West Virginia's medical cannabis program has generated $34 million in revenue without a single dollar spent, according to Mountain State Spotlight. The accumulation suggests a gap between licensing activity and legislative action on how to deploy the funds—a pattern consistent with related coverage showing the state House debating revenue allocation in March 2026 and Gov. Morrisey vetoing a revised $38 million spending bill in April.

The revenue holdup occurs amid broader regulatory uncertainty. Recent coverage indicates West Virginia has explored expanding its medical program and entertained legalization ballot measures, while federal reclassification discussions and neighboring states' recreational markets have already pressured in-state pricing and patient behavior. Whether the legislature can agree on a spending framework—and whether the governor will sign it—remains the immediate test of whether collected funds translate to program investment.

Observers should track whether the state passes a new allocation bill and whether the governor signs it, as prolonged gridlock could signal deeper political division over cannabis policy priorities in West Virginia.